Life Sciences

Finding sustainability in biotechnology, pharmaceutical and medical technology

Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.

Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.

We cover key issues in these areas:

Contact us

Request or call a meeting
If you have a specific service need or inquiry, please contact our Business Development Program Office team.

Tel: +62 21 5289 5672
Tel: +62 21 5289 5136
Tel: +62 21 5289 5138

Connect with us

Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.

EY-Applying IFRS 10 and IFRS 11

Applying IFRS 10 and IFRS 11

How will IFRS 10 and IFRS 11 impact collaboration arrangements in the life sciences industry? We explain.

Citizen Today special edition: health care

Citizen Today special edition: health care

Conversations in health care, a special edition, features interviews with health care leaders from around the world.